acetylglucosamine has been researched along with Cancer of Pancreas in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (21.43) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (42.86) | 24.3611 |
| 2020's | 5 (35.71) | 2.80 |
| Authors | Studies |
|---|---|
| Fujii, C; Harumiya, S; Kawakubo, M; Matoba, H; Nakayama, J; Yamanoi, K; Yuki, A | 1 |
| Fan, Z; Geng, D; Lai, Z; Qin, W; Wang, Y; Wu, L; Yang, W; Yi, W; Zhang, J; Zhou, H; Zhou, R; Zhu, Q | 1 |
| Agatemor, C; Buettner, M; Dammen-Brower, K; Fernandez-Gil, BI; Gowda, P; Khare, P; Le, A; Mathew, MP; Otamendi-Lopez, A; Quinoñes-Hinojosa, A; Saeui, CT; Shah, SR; Yang, S; Yarema, KJ; Zhang, C; Zhang, H | 1 |
| Chen, Y; McDonald, JM; Sun, Y; Xu, F; Yang, SZ; Yuan, K; Zhao, X; Zhou, T | 1 |
| Chen, JZ; Chen, S; Hu, JF; Huang, L; Huang, Y; Li, G; Liao, CY; Pan, JJ; Shen, BY; Tian, YF; Wang, YD; Wang, ZW; Yang, C; Zhan, Q | 1 |
| Fujii, C; Nakayama, J; Ohya, A; Shimojo, H; Yamanoi, K | 1 |
| Nakayama, J; Yamanoi, K | 1 |
| Chang, MC; Chang, YT; Chen, YJ; Hsieh, PK; Hu, CM; Jeng, YM; Lee, EYP; Lee, WH; Tien, SC | 1 |
| Banerjee, S; Chugh, R; Dudeja, V; McGinn, O; Saluja, AK; Sangwan, V; Vickers, SM | 1 |
| Gao, J; Gu, Y; Han, C; Liu, H; Ma, L; Sun, X; Yu, W; Zhang, X | 1 |
| Allen, PJ; Brand, RE; Cao, Z; Dai, J; Feng, Z; Haab, BB; Hostetter, G; Partyka, K; Simeone, DM; Sinha, J; Tang, H | 1 |
| Ishizuka, I; Kosaki, G; Yamakawa, T; Yamamoto, T | 1 |
| Ashihara, T; Kawai, K; Yamaguchi, N | 1 |
| Carter, TH; Zelinsky-Papez, K; Zimmerman, JA | 1 |
1 review(s) available for acetylglucosamine and Cancer of Pancreas
| Article | Year |
|---|---|
Reduced αGlcNAc glycosylation on gastric gland mucin is a biomarker of malignant potential for gastric cancer, Barrett's adenocarcinoma, and pancreatic cancer.
Topics: Acetylglucosamine; Adenocarcinoma; Animals; Barrett Esophagus; Biomarkers, Tumor; Gastric Mucins; Glycosylation; Humans; Pancreatic Neoplasms; Stomach Neoplasms | 2018 |
13 other study(ies) available for acetylglucosamine and Cancer of Pancreas
| Article | Year |
|---|---|
Glycosylation of MUC6 by α1,4-linked N-acetylglucosamine enhances suppression of pancreatic cancer malignancy.
Topics: Acetylglucosamine; Biomarkers, Tumor; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Cell Movement; Cell Proliferation; Glycosylation; Humans; Mucin-6; N-Acetylglucosaminyltransferases; Pancreatic Neoplasms; Prognosis; RNA, Messenger; Trefoil Factor-2; Tumor Suppressor Proteins | 2022 |
O-GlcNAcylation promotes pancreatic tumor growth by regulating malate dehydrogenase 1.
Topics: Acetylglucosamine; Animals; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Glutamine; Malate Dehydrogenase; Mice; Mice, Nude; N-Acetylglucosaminyltransferases; Pancreatic Neoplasms; Proto-Oncogene Proteins p21(ras); Serine | 2022 |
Anticancer Properties of Hexosamine Analogs Designed to Attenuate Metabolic Flux through the Hexosamine Biosynthetic Pathway.
Topics: Acetylglucosamine; Animals; Antineoplastic Agents; Biosynthetic Pathways; Glucose; Hexosamines; Pancreatic Neoplasms; Uridine Diphosphate | 2023 |
Regulation of pancreatic cancer TRAIL resistance by protein O-GlcNAcylation.
Topics: Acetylglucosamine; Animals; Cell Line, Tumor; Drug Resistance, Neoplasm; Humans; Male; Mice; Mice, Knockout; Mice, Nude; N-Acetylglucosaminyltransferases; Pancreatic Neoplasms; Signal Transduction; TNF-Related Apoptosis-Inducing Ligand | 2020 |
SHCBP1 interacting with EOGT enhances O-GlcNAcylation of NOTCH1 and promotes the development of pancreatic cancer.
Topics: Acetylation; Acetylglucosamine; Animals; Cell Line, Tumor; Female; HEK293 Cells; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Middle Aged; N-Acetylglucosaminyltransferases; Neoplasm Metastasis; Pancreatic Neoplasms; Protein Binding; Receptor, Notch1; Shc Signaling Adaptor Proteins | 2021 |
Gastric gland mucin-specific O-glycan expression decreases with tumor progression from precursor lesions to pancreatic cancer.
Topics: Acetylglucosamine; Biomarkers, Tumor; Carbohydrate Conformation; Carcinogenesis; Carcinoma, Pancreatic Ductal; Disease Progression; Gastric Mucosa; Glycosylation; Humans; Mucin 5AC; Mucin-6; Pancreatic Neoplasms; Precancerous Conditions; Protein Processing, Post-Translational | 2017 |
High Glucose Triggers Nucleotide Imbalance through O-GlcNAcylation of Key Enzymes and Induces KRAS Mutation in Pancreatic Cells.
Topics: Acetylation; Acetylglucosamine; Acetyltransferases; Adult; Aged; Animals; Carcinoma, Pancreatic Ductal; Cell Transformation, Neoplastic; Cells, Cultured; DNA Damage; Dose-Response Relationship, Drug; Enzymes; Female; Glucose; HEK293 Cells; Humans; Infant, Newborn; Male; Metabolic Networks and Pathways; Mice; Mice, Inbred C57BL; Middle Aged; Mutagenesis; Mutation; Nucleotides; Pancreas; Pancreatic Neoplasms; Protein Processing, Post-Translational; Proto-Oncogene Proteins p21(ras); Young Adult | 2019 |
Triptolide-induced cell death in pancreatic cancer is mediated by O-GlcNAc modification of transcription factor Sp1.
Topics: Acetylglucosamine; Active Transport, Cell Nucleus; Antineoplastic Agents, Alkylating; Cell Death; Cell Line, Tumor; Cell Nucleus; Cell Survival; Diterpenes; DNA-Binding Proteins; Down-Regulation; Epoxy Compounds; Gene Expression Regulation, Neoplastic; Glycosylation; Heat Shock Transcription Factors; HSP70 Heat-Shock Proteins; Humans; N-Acetylglucosaminyltransferases; Neoplasm Proteins; NF-kappa B; Pancreatic Neoplasms; Phenanthrenes; Signal Transduction; Sp1 Transcription Factor; Transcription Factors | 2013 |
O-GlcNAcylation is increased in prostate cancer tissues and enhances malignancy of prostate cancer cells.
Topics: Acetylglucosamine; Cadherins; Catenins; Cell Line, Tumor; Cell Movement; Cytoskeleton; Humans; Immunohistochemistry; Liver Neoplasms; Male; N-Acetylglucosaminyltransferases; Pancreatic Neoplasms; Promoter Regions, Genetic; Prostatic Neoplasms | 2014 |
A Gastric Glycoform of MUC5AC Is a Biomarker of Mucinous Cysts of the Pancreas.
Topics: Acetylglucosamine; Adenocarcinoma, Mucinous; Biomarkers; Carcinoma, Pancreatic Ductal; Carcinoma, Papillary; Cohort Studies; Glycosylation; Heparan Sulfate Proteoglycans; Humans; Mucin 5AC; N-Acetylglucosaminyltransferases; Pancreatic Cyst; Pancreatic Neoplasms; Peptide Fragments | 2016 |
Heterogeneity of carcinoembryonic antigen. II. Monosaccharide composition of concanavalin A-reactive and -nonreactive CEA.
Topics: Acetylgalactosamine; Acetylglucosamine; Binding Sites; Carcinoembryonic Antigen; Chromatography, Affinity; Concanavalin A; Fucose; Galactose; Glucosamine; Humans; Liver Neoplasms; Mannose; Neoplasm Metastasis; Pancreatic Neoplasms; Protein Binding; Rectal Neoplasms; Sialic Acids | 1975 |
Discrimination of gamma-glutamyltranspeptidase from normal and carcinomatous pancreas.
Topics: Acetylglucosamine; Chromatography, Affinity; Chromatography, Ion Exchange; Electrophoresis, Polyacrylamide Gel; gamma-Glutamyltransferase; Hot Temperature; Humans; Isoelectric Point; Lectins; Molecular Weight; Pancreas; Pancreatic Neoplasms | 1986 |
Isolation and characterization of chemically transformed pancreatic acinar cell lines from young and old mice.
Topics: Acetylglucosamine; Aging; Animals; Cell Division; Cell Line; Cell Transformation, Neoplastic; Isoenzymes; Karyotyping; L-Lactate Dehydrogenase; Lectins; Male; Methylnitrosourea; Mice; Pancreatic Neoplasms; Phenotype; Plant Lectins; Soybean Proteins; Tetradecanoylphorbol Acetate | 1987 |